nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCB1—colon cancer	0.205	1	CbGaD
Nifedipine—ABCC3—Fluorouracil—colon cancer	0.0742	0.137	CbGbCtD
Nifedipine—ABCC3—Vincristine—colon cancer	0.0676	0.124	CbGbCtD
Nifedipine—ABCC3—Methotrexate—colon cancer	0.0409	0.0754	CbGbCtD
Nifedipine—ABCC2—Irinotecan—colon cancer	0.0352	0.0647	CbGbCtD
Nifedipine—CYP2A6—Fluorouracil—colon cancer	0.033	0.0607	CbGbCtD
Nifedipine—ABCC2—Vincristine—colon cancer	0.0307	0.0566	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0235	0.0432	CbGbCtD
Nifedipine—CYP3A7—Irinotecan—colon cancer	0.0235	0.0432	CbGbCtD
Nifedipine—CYP2B6—Irinotecan—colon cancer	0.0224	0.0412	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0205	0.0378	CbGbCtD
Nifedipine—CYP3A7—Vincristine—colon cancer	0.0205	0.0378	CbGbCtD
Nifedipine—CYP2C9—Capecitabine—colon cancer	0.0191	0.0352	CbGbCtD
Nifedipine—ABCC2—Methotrexate—colon cancer	0.0186	0.0343	CbGbCtD
Nifedipine—CYP3A5—Irinotecan—colon cancer	0.0176	0.0324	CbGbCtD
Nifedipine—CYP2C8—Fluorouracil—colon cancer	0.0163	0.0299	CbGbCtD
Nifedipine—CYP3A5—Vincristine—colon cancer	0.0154	0.0283	CbGbCtD
Nifedipine—CYP1A2—Fluorouracil—colon cancer	0.0126	0.0232	CbGbCtD
Nifedipine—ABCB1—Irinotecan—colon cancer	0.0115	0.0211	CbGbCtD
Nifedipine—CYP2C9—Fluorouracil—colon cancer	0.0113	0.0209	CbGbCtD
Nifedipine—ABCB1—Vincristine—colon cancer	0.01	0.0184	CbGbCtD
Nifedipine—CYP3A4—Irinotecan—colon cancer	0.00687	0.0126	CbGbCtD
Nifedipine—ABCB1—Methotrexate—colon cancer	0.00607	0.0112	CbGbCtD
Nifedipine—CYP3A4—Vincristine—colon cancer	0.006	0.011	CbGbCtD
Nifedipine—ABCC2—bile—colon cancer	0.00451	0.0841	CbGeAlD
Nifedipine—ABCC3—gall bladder—colon cancer	0.00157	0.0292	CbGeAlD
Nifedipine—CALM2—endothelium—colon cancer	0.00131	0.0243	CbGeAlD
Nifedipine—CALM1—endothelium—colon cancer	0.0013	0.0242	CbGeAlD
Nifedipine—CALM2—blood vessel—colon cancer	0.0012	0.0224	CbGeAlD
Nifedipine—CALM1—blood vessel—colon cancer	0.0012	0.0223	CbGeAlD
Nifedipine—CALM2—gall bladder—colon cancer	0.00113	0.0211	CbGeAlD
Nifedipine—CACNA1H—smooth muscle tissue—colon cancer	0.00113	0.021	CbGeAlD
Nifedipine—CACNA1C—smooth muscle tissue—colon cancer	0.000858	0.016	CbGeAlD
Nifedipine—CACNB2—digestive system—colon cancer	0.00084	0.0157	CbGeAlD
Nifedipine—ABCC3—renal system—colon cancer	0.000752	0.014	CbGeAlD
Nifedipine—CACNB2—vagina—colon cancer	0.000742	0.0138	CbGeAlD
Nifedipine—CACNA2D1—bone marrow—colon cancer	0.000727	0.0136	CbGeAlD
Nifedipine—CALM3—smooth muscle tissue—colon cancer	0.000719	0.0134	CbGeAlD
Nifedipine—CALM2—embryo—colon cancer	0.000718	0.0134	CbGeAlD
Nifedipine—CALM1—embryo—colon cancer	0.000715	0.0133	CbGeAlD
Nifedipine—CYP3A7—liver—colon cancer	0.000706	0.0132	CbGeAlD
Nifedipine—CACNA2D1—vagina—colon cancer	0.000697	0.013	CbGeAlD
Nifedipine—CACNA1C—digestive system—colon cancer	0.000678	0.0126	CbGeAlD
Nifedipine—CACNA1H—liver—colon cancer	0.000663	0.0124	CbGeAlD
Nifedipine—CACNB2—liver—colon cancer	0.000626	0.0117	CbGeAlD
Nifedipine—ABCC3—digestive system—colon cancer	0.000617	0.0115	CbGeAlD
Nifedipine—ABCC2—renal system—colon cancer	0.000601	0.0112	CbGeAlD
Nifedipine—CYP3A7-CYP3A51P—liver—colon cancer	0.0006	0.0112	CbGeAlD
Nifedipine—CACNA1C—vagina—colon cancer	0.000599	0.0112	CbGeAlD
Nifedipine—CACNA2D1—liver—colon cancer	0.000588	0.011	CbGeAlD
Nifedipine—CALM2—epithelium—colon cancer	0.000586	0.0109	CbGeAlD
Nifedipine—CALM1—epithelium—colon cancer	0.000583	0.0109	CbGeAlD
Nifedipine—CYP2A6—vagina—colon cancer	0.000581	0.0108	CbGeAlD
Nifedipine—CALM2—smooth muscle tissue—colon cancer	0.000565	0.0105	CbGeAlD
Nifedipine—CALM1—smooth muscle tissue—colon cancer	0.000562	0.0105	CbGeAlD
Nifedipine—CACNA1D—liver—colon cancer	0.000547	0.0102	CbGeAlD
Nifedipine—CALM2—renal system—colon cancer	0.000544	0.0101	CbGeAlD
Nifedipine—CALM1—renal system—colon cancer	0.000541	0.0101	CbGeAlD
Nifedipine—CALM3—bone marrow—colon cancer	0.000523	0.00975	CbGeAlD
Nifedipine—CACNA1H—lymph node—colon cancer	0.000508	0.00947	CbGeAlD
Nifedipine—CALM3—vagina—colon cancer	0.000501	0.00934	CbGeAlD
Nifedipine—ABCC2—digestive system—colon cancer	0.000493	0.00918	CbGeAlD
Nifedipine—CYP2A6—liver—colon cancer	0.00049	0.00914	CbGeAlD
Nifedipine—CACNB2—lymph node—colon cancer	0.00048	0.00894	CbGeAlD
Nifedipine—ABCB1—blood vessel—colon cancer	0.000478	0.00892	CbGeAlD
Nifedipine—ABCC3—liver—colon cancer	0.000459	0.00856	CbGeAlD
Nifedipine—CALM2—lymphoid tissue—colon cancer	0.000451	0.00841	CbGeAlD
Nifedipine—CACNA2D1—lymph node—colon cancer	0.000451	0.0084	CbGeAlD
Nifedipine—CYP2C8—renal system—colon cancer	0.00045	0.0084	CbGeAlD
Nifedipine—CALM1—lymphoid tissue—colon cancer	0.000449	0.00837	CbGeAlD
Nifedipine—CYP1A1—epithelium—colon cancer	0.000448	0.00836	CbGeAlD
Nifedipine—CALM2—digestive system—colon cancer	0.000446	0.00831	CbGeAlD
Nifedipine—CALM1—digestive system—colon cancer	0.000444	0.00827	CbGeAlD
Nifedipine—CALM3—liver—colon cancer	0.000423	0.00788	CbGeAlD
Nifedipine—CYP1A2—renal system—colon cancer	0.000422	0.00786	CbGeAlD
Nifedipine—CACNA1D—lymph node—colon cancer	0.000419	0.00782	CbGeAlD
Nifedipine—CYP1A1—renal system—colon cancer	0.000416	0.00775	CbGeAlD
Nifedipine—CALM2—bone marrow—colon cancer	0.000411	0.00766	CbGeAlD
Nifedipine—CALM1—bone marrow—colon cancer	0.000409	0.00762	CbGeAlD
Nifedipine—CYP3A5—renal system—colon cancer	0.000407	0.00758	CbGeAlD
Nifedipine—CYP2B6—renal system—colon cancer	0.000404	0.00753	CbGeAlD
Nifedipine—CALM2—vagina—colon cancer	0.000394	0.00734	CbGeAlD
Nifedipine—CALM1—vagina—colon cancer	0.000392	0.0073	CbGeAlD
Nifedipine—CACNA1C—lymph node—colon cancer	0.000387	0.00722	CbGeAlD
Nifedipine—CYP2E1—renal system—colon cancer	0.000379	0.00707	CbGeAlD
Nifedipine—ABCC2—liver—colon cancer	0.000367	0.00684	CbGeAlD
Nifedipine—ABCC3—lymph node—colon cancer	0.000352	0.00656	CbGeAlD
Nifedipine—CYP1A2—digestive system—colon cancer	0.000346	0.00644	CbGeAlD
Nifedipine—CYP1A1—digestive system—colon cancer	0.000341	0.00636	CbGeAlD
Nifedipine—CYP2B6—lymphoid tissue—colon cancer	0.000336	0.00625	CbGeAlD
Nifedipine—CYP3A5—digestive system—colon cancer	0.000333	0.00622	CbGeAlD
Nifedipine—CALM2—liver—colon cancer	0.000332	0.00619	CbGeAlD
Nifedipine—CYP2B6—digestive system—colon cancer	0.000331	0.00618	CbGeAlD
Nifedipine—CALM1—liver—colon cancer	0.000331	0.00616	CbGeAlD
Nifedipine—CYP2C9—digestive system—colon cancer	0.000328	0.00612	CbGeAlD
Nifedipine—CYP2C8—vagina—colon cancer	0.000326	0.00608	CbGeAlD
Nifedipine—CALM3—lymph node—colon cancer	0.000324	0.00604	CbGeAlD
Nifedipine—CYP2E1—lymphoid tissue—colon cancer	0.000315	0.00587	CbGeAlD
Nifedipine—CYP2E1—digestive system—colon cancer	0.000311	0.0058	CbGeAlD
Nifedipine—CYP3A4—renal system—colon cancer	0.000305	0.00569	CbGeAlD
Nifedipine—CYP1A1—vagina—colon cancer	0.000301	0.00561	CbGeAlD
Nifedipine—CYP2D6—renal system—colon cancer	0.0003	0.0056	CbGeAlD
Nifedipine—CYP3A5—vagina—colon cancer	0.000294	0.00549	CbGeAlD
Nifedipine—Nisoldipine—ABCB1—colon cancer	0.000294	0.238	CrCbGaD
Nifedipine—CYP2B6—vagina—colon cancer	0.000293	0.00546	CbGeAlD
Nifedipine—ABCB1—embryo—colon cancer	0.000285	0.00532	CbGeAlD
Nifedipine—ABCC2—lymph node—colon cancer	0.000281	0.00524	CbGeAlD
Nifedipine—CYP2C8—liver—colon cancer	0.000275	0.00513	CbGeAlD
Nifedipine—Nitrendipine—ABCB1—colon cancer	0.000275	0.223	CrCbGaD
Nifedipine—CYP1A2—liver—colon cancer	0.000258	0.0048	CbGeAlD
Nifedipine—CALM2—lymph node—colon cancer	0.000255	0.00475	CbGeAlD
Nifedipine—CYP1A1—liver—colon cancer	0.000254	0.00474	CbGeAlD
Nifedipine—CALM1—lymph node—colon cancer	0.000253	0.00472	CbGeAlD
Nifedipine—CYP3A4—digestive system—colon cancer	0.00025	0.00466	CbGeAlD
Nifedipine—CYP3A5—liver—colon cancer	0.000248	0.00463	CbGeAlD
Nifedipine—CYP2B6—liver—colon cancer	0.000247	0.0046	CbGeAlD
Nifedipine—CYP2D6—digestive system—colon cancer	0.000246	0.00459	CbGeAlD
Nifedipine—CYP2C9—liver—colon cancer	0.000244	0.00456	CbGeAlD
Nifedipine—Amlodipine—ABCB1—colon cancer	0.000237	0.192	CrCbGaD
Nifedipine—ABCB1—epithelium—colon cancer	0.000233	0.00434	CbGeAlD
Nifedipine—CYP2E1—liver—colon cancer	0.000232	0.00432	CbGeAlD
Nifedipine—Felodipine—ABCB1—colon cancer	0.000219	0.178	CrCbGaD
Nifedipine—ABCB1—renal system—colon cancer	0.000216	0.00403	CbGeAlD
Nifedipine—Nicardipine—ABCB1—colon cancer	0.000208	0.169	CrCbGaD
Nifedipine—Epistaxis—Capecitabine—colon cancer	0.000195	0.00154	CcSEcCtD
Nifedipine—CYP1A1—lymph node—colon cancer	0.000195	0.00363	CbGeAlD
Nifedipine—Discomfort—Fluorouracil—colon cancer	0.000195	0.00153	CcSEcCtD
Nifedipine—Shock—Irinotecan—colon cancer	0.000194	0.00153	CcSEcCtD
Nifedipine—Nervous system disorder—Irinotecan—colon cancer	0.000193	0.00152	CcSEcCtD
Nifedipine—Agranulocytosis—Capecitabine—colon cancer	0.000193	0.00152	CcSEcCtD
Nifedipine—Thrombocytopenia—Irinotecan—colon cancer	0.000193	0.00152	CcSEcCtD
Nifedipine—Anorexia—Vincristine—colon cancer	0.000193	0.00152	CcSEcCtD
Nifedipine—Hyperhidrosis—Irinotecan—colon cancer	0.000191	0.0015	CcSEcCtD
Nifedipine—Confusional state—Fluorouracil—colon cancer	0.00019	0.0015	CcSEcCtD
Nifedipine—Mood swings—Methotrexate—colon cancer	0.000189	0.00149	CcSEcCtD
Nifedipine—Hypotension—Vincristine—colon cancer	0.000189	0.00149	CcSEcCtD
Nifedipine—Bradycardia—Capecitabine—colon cancer	0.000189	0.00149	CcSEcCtD
Nifedipine—Oedema—Fluorouracil—colon cancer	0.000189	0.00149	CcSEcCtD
Nifedipine—Anaphylactic shock—Fluorouracil—colon cancer	0.000189	0.00149	CcSEcCtD
Nifedipine—Anorexia—Irinotecan—colon cancer	0.000188	0.00148	CcSEcCtD
Nifedipine—Ataxia—Methotrexate—colon cancer	0.000188	0.00148	CcSEcCtD
Nifedipine—Haemoglobin—Capecitabine—colon cancer	0.000187	0.00147	CcSEcCtD
Nifedipine—CYP3A4—liver—colon cancer	0.000186	0.00348	CbGeAlD
Nifedipine—Rhinitis—Capecitabine—colon cancer	0.000186	0.00147	CcSEcCtD
Nifedipine—Haemorrhage—Capecitabine—colon cancer	0.000186	0.00146	CcSEcCtD
Nifedipine—Hepatitis—Capecitabine—colon cancer	0.000186	0.00146	CcSEcCtD
Nifedipine—Nervous system disorder—Fluorouracil—colon cancer	0.000185	0.00146	CcSEcCtD
Nifedipine—Thrombocytopenia—Fluorouracil—colon cancer	0.000185	0.00146	CcSEcCtD
Nifedipine—Hypoaesthesia—Capecitabine—colon cancer	0.000185	0.00145	CcSEcCtD
Nifedipine—Liver function test abnormal—Methotrexate—colon cancer	0.000185	0.00145	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000184	0.00145	CcSEcCtD
Nifedipine—Pharyngitis—Capecitabine—colon cancer	0.000184	0.00145	CcSEcCtD
Nifedipine—Tachycardia—Fluorouracil—colon cancer	0.000184	0.00145	CcSEcCtD
Nifedipine—Hypotension—Irinotecan—colon cancer	0.000184	0.00145	CcSEcCtD
Nifedipine—CYP2D6—liver—colon cancer	0.000183	0.00342	CbGeAlD
Nifedipine—Urinary tract disorder—Capecitabine—colon cancer	0.000183	0.00144	CcSEcCtD
Nifedipine—Insomnia—Vincristine—colon cancer	0.000183	0.00144	CcSEcCtD
Nifedipine—Oedema peripheral—Capecitabine—colon cancer	0.000183	0.00144	CcSEcCtD
Nifedipine—Connective tissue disorder—Capecitabine—colon cancer	0.000183	0.00144	CcSEcCtD
Nifedipine—Urethral disorder—Capecitabine—colon cancer	0.000182	0.00143	CcSEcCtD
Nifedipine—Paraesthesia—Vincristine—colon cancer	0.000182	0.00143	CcSEcCtD
Nifedipine—Breast disorder—Methotrexate—colon cancer	0.000181	0.00142	CcSEcCtD
Nifedipine—Anorexia—Fluorouracil—colon cancer	0.00018	0.00142	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00018	0.00142	CcSEcCtD
Nifedipine—ABCB1—lymphoid tissue—colon cancer	0.000179	0.00334	CbGeAlD
Nifedipine—Visual impairment—Capecitabine—colon cancer	0.000179	0.00141	CcSEcCtD
Nifedipine—Insomnia—Irinotecan—colon cancer	0.000178	0.0014	CcSEcCtD
Nifedipine—ABCB1—digestive system—colon cancer	0.000177	0.0033	CbGeAlD
Nifedipine—Paraesthesia—Irinotecan—colon cancer	0.000177	0.00139	CcSEcCtD
Nifedipine—Hypotension—Fluorouracil—colon cancer	0.000176	0.00139	CcSEcCtD
Nifedipine—Decreased appetite—Vincristine—colon cancer	0.000176	0.00139	CcSEcCtD
Nifedipine—Dyspnoea—Irinotecan—colon cancer	0.000176	0.00138	CcSEcCtD
Nifedipine—Erythema multiforme—Capecitabine—colon cancer	0.000176	0.00138	CcSEcCtD
Nifedipine—Somnolence—Irinotecan—colon cancer	0.000175	0.00138	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Vincristine—colon cancer	0.000175	0.00138	CcSEcCtD
Nifedipine—Fatigue—Vincristine—colon cancer	0.000175	0.00137	CcSEcCtD
Nifedipine—Eye disorder—Capecitabine—colon cancer	0.000174	0.00137	CcSEcCtD
Nifedipine—Dyspepsia—Irinotecan—colon cancer	0.000174	0.00137	CcSEcCtD
Nifedipine—Tinnitus—Capecitabine—colon cancer	0.000173	0.00136	CcSEcCtD
Nifedipine—Constipation—Vincristine—colon cancer	0.000173	0.00136	CcSEcCtD
Nifedipine—Pain—Vincristine—colon cancer	0.000173	0.00136	CcSEcCtD
Nifedipine—Flushing—Capecitabine—colon cancer	0.000172	0.00136	CcSEcCtD
Nifedipine—Cardiac disorder—Capecitabine—colon cancer	0.000172	0.00136	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000172	0.00135	CcSEcCtD
Nifedipine—Decreased appetite—Irinotecan—colon cancer	0.000171	0.00135	CcSEcCtD
Nifedipine—Eosinophilia—Methotrexate—colon cancer	0.000171	0.00135	CcSEcCtD
Nifedipine—Insomnia—Fluorouracil—colon cancer	0.000171	0.00134	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00017	0.00134	CcSEcCtD
Nifedipine—Fatigue—Irinotecan—colon cancer	0.00017	0.00134	CcSEcCtD
Nifedipine—Paraesthesia—Fluorouracil—colon cancer	0.00017	0.00133	CcSEcCtD
Nifedipine—Pain—Irinotecan—colon cancer	0.000169	0.00133	CcSEcCtD
Nifedipine—Constipation—Irinotecan—colon cancer	0.000169	0.00133	CcSEcCtD
Nifedipine—Angiopathy—Capecitabine—colon cancer	0.000169	0.00133	CcSEcCtD
Nifedipine—Dyspnoea—Fluorouracil—colon cancer	0.000168	0.00133	CcSEcCtD
Nifedipine—Somnolence—Fluorouracil—colon cancer	0.000168	0.00132	CcSEcCtD
Nifedipine—Immune system disorder—Capecitabine—colon cancer	0.000168	0.00132	CcSEcCtD
Nifedipine—Mediastinal disorder—Capecitabine—colon cancer	0.000167	0.00132	CcSEcCtD
Nifedipine—Chills—Capecitabine—colon cancer	0.000167	0.00131	CcSEcCtD
Nifedipine—Dyspepsia—Fluorouracil—colon cancer	0.000166	0.00131	CcSEcCtD
Nifedipine—Arrhythmia—Capecitabine—colon cancer	0.000166	0.00131	CcSEcCtD
Nifedipine—Abdominal discomfort—Methotrexate—colon cancer	0.000166	0.0013	CcSEcCtD
Nifedipine—Gastrointestinal pain—Vincristine—colon cancer	0.000166	0.0013	CcSEcCtD
Nifedipine—Decreased appetite—Fluorouracil—colon cancer	0.000164	0.00129	CcSEcCtD
Nifedipine—Alopecia—Capecitabine—colon cancer	0.000164	0.00129	CcSEcCtD
Nifedipine—ABCB1—bone marrow—colon cancer	0.000163	0.00304	CbGeAlD
Nifedipine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000163	0.00128	CcSEcCtD
Nifedipine—Mental disorder—Capecitabine—colon cancer	0.000163	0.00128	CcSEcCtD
Nifedipine—Feeling abnormal—Irinotecan—colon cancer	0.000162	0.00128	CcSEcCtD
Nifedipine—Malnutrition—Capecitabine—colon cancer	0.000162	0.00127	CcSEcCtD
Nifedipine—Erythema—Capecitabine—colon cancer	0.000162	0.00127	CcSEcCtD
Nifedipine—Dysuria—Methotrexate—colon cancer	0.000162	0.00127	CcSEcCtD
Nifedipine—Pain—Fluorouracil—colon cancer	0.000162	0.00127	CcSEcCtD
Nifedipine—Gastrointestinal pain—Irinotecan—colon cancer	0.000161	0.00127	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Methotrexate—colon cancer	0.000161	0.00126	CcSEcCtD
Nifedipine—Abdominal pain—Vincristine—colon cancer	0.00016	0.00126	CcSEcCtD
Nifedipine—Body temperature increased—Vincristine—colon cancer	0.00016	0.00126	CcSEcCtD
Nifedipine—Flatulence—Capecitabine—colon cancer	0.000159	0.00125	CcSEcCtD
Nifedipine—Erectile dysfunction—Methotrexate—colon cancer	0.000159	0.00125	CcSEcCtD
Nifedipine—Dysgeusia—Capecitabine—colon cancer	0.000158	0.00125	CcSEcCtD
Nifedipine—Photosensitivity reaction—Methotrexate—colon cancer	0.000158	0.00124	CcSEcCtD
Nifedipine—ABCB1—vagina—colon cancer	0.000156	0.00292	CbGeAlD
Nifedipine—Back pain—Capecitabine—colon cancer	0.000156	0.00123	CcSEcCtD
Nifedipine—Abdominal pain—Irinotecan—colon cancer	0.000156	0.00123	CcSEcCtD
Nifedipine—Body temperature increased—Irinotecan—colon cancer	0.000156	0.00123	CcSEcCtD
Nifedipine—Feeling abnormal—Fluorouracil—colon cancer	0.000156	0.00122	CcSEcCtD
Nifedipine—Muscle spasms—Capecitabine—colon cancer	0.000155	0.00122	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000153	0.0012	CcSEcCtD
Nifedipine—Vision blurred—Capecitabine—colon cancer	0.000152	0.0012	CcSEcCtD
Nifedipine—Tremor—Capecitabine—colon cancer	0.000152	0.00119	CcSEcCtD
Nifedipine—Ill-defined disorder—Capecitabine—colon cancer	0.00015	0.00118	CcSEcCtD
Nifedipine—Urticaria—Fluorouracil—colon cancer	0.00015	0.00118	CcSEcCtD
Nifedipine—Conjunctivitis—Methotrexate—colon cancer	0.00015	0.00118	CcSEcCtD
Nifedipine—Anaemia—Capecitabine—colon cancer	0.000149	0.00118	CcSEcCtD
Nifedipine—Body temperature increased—Fluorouracil—colon cancer	0.000149	0.00117	CcSEcCtD
Nifedipine—Hypersensitivity—Vincristine—colon cancer	0.000149	0.00117	CcSEcCtD
Nifedipine—Sweating—Methotrexate—colon cancer	0.000148	0.00116	CcSEcCtD
Nifedipine—Haematuria—Methotrexate—colon cancer	0.000147	0.00116	CcSEcCtD
Nifedipine—Malaise—Capecitabine—colon cancer	0.000146	0.00115	CcSEcCtD
Nifedipine—Hepatobiliary disease—Methotrexate—colon cancer	0.000146	0.00115	CcSEcCtD
Nifedipine—Epistaxis—Methotrexate—colon cancer	0.000145	0.00114	CcSEcCtD
Nifedipine—Vertigo—Capecitabine—colon cancer	0.000145	0.00114	CcSEcCtD
Nifedipine—Hypersensitivity—Irinotecan—colon cancer	0.000145	0.00114	CcSEcCtD
Nifedipine—Asthenia—Vincristine—colon cancer	0.000145	0.00114	CcSEcCtD
Nifedipine—Syncope—Capecitabine—colon cancer	0.000145	0.00114	CcSEcCtD
Nifedipine—Leukopenia—Capecitabine—colon cancer	0.000145	0.00114	CcSEcCtD
Nifedipine—Agranulocytosis—Methotrexate—colon cancer	0.000144	0.00113	CcSEcCtD
Nifedipine—Palpitations—Capecitabine—colon cancer	0.000143	0.00112	CcSEcCtD
Nifedipine—Loss of consciousness—Capecitabine—colon cancer	0.000142	0.00112	CcSEcCtD
Nifedipine—Asthenia—Irinotecan—colon cancer	0.000141	0.00111	CcSEcCtD
Nifedipine—Cough—Capecitabine—colon cancer	0.000141	0.00111	CcSEcCtD
Nifedipine—Hypersensitivity—Fluorouracil—colon cancer	0.000139	0.0011	CcSEcCtD
Nifedipine—Haemoglobin—Methotrexate—colon cancer	0.000139	0.00109	CcSEcCtD
Nifedipine—Diarrhoea—Vincristine—colon cancer	0.000139	0.00109	CcSEcCtD
Nifedipine—Haemorrhage—Methotrexate—colon cancer	0.000138	0.00109	CcSEcCtD
Nifedipine—Hepatitis—Methotrexate—colon cancer	0.000138	0.00109	CcSEcCtD
Nifedipine—Arthralgia—Capecitabine—colon cancer	0.000138	0.00108	CcSEcCtD
Nifedipine—Myalgia—Capecitabine—colon cancer	0.000138	0.00108	CcSEcCtD
Nifedipine—Chest pain—Capecitabine—colon cancer	0.000138	0.00108	CcSEcCtD
Nifedipine—Pharyngitis—Methotrexate—colon cancer	0.000137	0.00108	CcSEcCtD
Nifedipine—Anxiety—Capecitabine—colon cancer	0.000137	0.00108	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000137	0.00108	CcSEcCtD
Nifedipine—Urinary tract disorder—Methotrexate—colon cancer	0.000137	0.00107	CcSEcCtD
Nifedipine—Discomfort—Capecitabine—colon cancer	0.000136	0.00107	CcSEcCtD
Nifedipine—Urethral disorder—Methotrexate—colon cancer	0.000136	0.00107	CcSEcCtD
Nifedipine—Diarrhoea—Irinotecan—colon cancer	0.000135	0.00106	CcSEcCtD
Nifedipine—Dry mouth—Capecitabine—colon cancer	0.000135	0.00106	CcSEcCtD
Nifedipine—Dizziness—Vincristine—colon cancer	0.000134	0.00105	CcSEcCtD
Nifedipine—Pruritus—Fluorouracil—colon cancer	0.000134	0.00105	CcSEcCtD
Nifedipine—Visual impairment—Methotrexate—colon cancer	0.000133	0.00105	CcSEcCtD
Nifedipine—Confusional state—Capecitabine—colon cancer	0.000133	0.00105	CcSEcCtD
Nifedipine—Oedema—Capecitabine—colon cancer	0.000132	0.00104	CcSEcCtD
Nifedipine—ABCB1—liver—colon cancer	0.000132	0.00246	CbGeAlD
Nifedipine—Erythema multiforme—Methotrexate—colon cancer	0.000131	0.00103	CcSEcCtD
Nifedipine—Dizziness—Irinotecan—colon cancer	0.00013	0.00103	CcSEcCtD
Nifedipine—Shock—Capecitabine—colon cancer	0.00013	0.00102	CcSEcCtD
Nifedipine—Nervous system disorder—Capecitabine—colon cancer	0.000129	0.00102	CcSEcCtD
Nifedipine—Eye disorder—Methotrexate—colon cancer	0.000129	0.00102	CcSEcCtD
Nifedipine—Diarrhoea—Fluorouracil—colon cancer	0.000129	0.00102	CcSEcCtD
Nifedipine—Thrombocytopenia—Capecitabine—colon cancer	0.000129	0.00102	CcSEcCtD
Nifedipine—Tinnitus—Methotrexate—colon cancer	0.000129	0.00101	CcSEcCtD
Nifedipine—Tachycardia—Capecitabine—colon cancer	0.000129	0.00101	CcSEcCtD
Nifedipine—Vomiting—Vincristine—colon cancer	0.000129	0.00101	CcSEcCtD
Nifedipine—Cardiac disorder—Methotrexate—colon cancer	0.000128	0.00101	CcSEcCtD
Nifedipine—Skin disorder—Capecitabine—colon cancer	0.000128	0.00101	CcSEcCtD
Nifedipine—Rash—Vincristine—colon cancer	0.000128	0.001	CcSEcCtD
Nifedipine—Hyperhidrosis—Capecitabine—colon cancer	0.000128	0.001	CcSEcCtD
Nifedipine—Dermatitis—Vincristine—colon cancer	0.000128	0.001	CcSEcCtD
Nifedipine—Headache—Vincristine—colon cancer	0.000127	0.000998	CcSEcCtD
Nifedipine—Anorexia—Capecitabine—colon cancer	0.000126	0.00099	CcSEcCtD
Nifedipine—Angiopathy—Methotrexate—colon cancer	0.000125	0.000987	CcSEcCtD
Nifedipine—Vomiting—Irinotecan—colon cancer	0.000125	0.000987	CcSEcCtD
Nifedipine—Immune system disorder—Methotrexate—colon cancer	0.000125	0.000983	CcSEcCtD
Nifedipine—Dizziness—Fluorouracil—colon cancer	0.000125	0.000983	CcSEcCtD
Nifedipine—Mediastinal disorder—Methotrexate—colon cancer	0.000125	0.000981	CcSEcCtD
Nifedipine—Rash—Irinotecan—colon cancer	0.000124	0.000978	CcSEcCtD
Nifedipine—Dermatitis—Irinotecan—colon cancer	0.000124	0.000978	CcSEcCtD
Nifedipine—Chills—Methotrexate—colon cancer	0.000124	0.000976	CcSEcCtD
Nifedipine—Headache—Irinotecan—colon cancer	0.000124	0.000972	CcSEcCtD
Nifedipine—Hypotension—Capecitabine—colon cancer	0.000123	0.000971	CcSEcCtD
Nifedipine—Alopecia—Methotrexate—colon cancer	0.000122	0.000962	CcSEcCtD
Nifedipine—Mental disorder—Methotrexate—colon cancer	0.000121	0.000953	CcSEcCtD
Nifedipine—Erythema—Methotrexate—colon cancer	0.00012	0.000947	CcSEcCtD
Nifedipine—Malnutrition—Methotrexate—colon cancer	0.00012	0.000947	CcSEcCtD
Nifedipine—Nausea—Vincristine—colon cancer	0.00012	0.000946	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00012	0.000946	CcSEcCtD
Nifedipine—Vomiting—Fluorouracil—colon cancer	0.00012	0.000945	CcSEcCtD
Nifedipine—Insomnia—Capecitabine—colon cancer	0.000119	0.000939	CcSEcCtD
Nifedipine—Rash—Fluorouracil—colon cancer	0.000119	0.000937	CcSEcCtD
Nifedipine—Dermatitis—Fluorouracil—colon cancer	0.000119	0.000936	CcSEcCtD
Nifedipine—Paraesthesia—Capecitabine—colon cancer	0.000119	0.000933	CcSEcCtD
Nifedipine—Headache—Fluorouracil—colon cancer	0.000118	0.000931	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—colon cancer	0.000118	0.000928	CcSEcCtD
Nifedipine—Dyspnoea—Capecitabine—colon cancer	0.000118	0.000926	CcSEcCtD
Nifedipine—Nausea—Irinotecan—colon cancer	0.000117	0.000922	CcSEcCtD
Nifedipine—Back pain—Methotrexate—colon cancer	0.000116	0.000916	CcSEcCtD
Nifedipine—Dyspepsia—Capecitabine—colon cancer	0.000116	0.000914	CcSEcCtD
Nifedipine—Decreased appetite—Capecitabine—colon cancer	0.000115	0.000903	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000114	0.000897	CcSEcCtD
Nifedipine—Fatigue—Capecitabine—colon cancer	0.000114	0.000895	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—colon cancer	0.000113	0.000893	CcSEcCtD
Nifedipine—Pain—Capecitabine—colon cancer	0.000113	0.000888	CcSEcCtD
Nifedipine—Constipation—Capecitabine—colon cancer	0.000113	0.000888	CcSEcCtD
Nifedipine—Nausea—Fluorouracil—colon cancer	0.000112	0.000883	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—colon cancer	0.000112	0.000879	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—colon cancer	0.000111	0.000876	CcSEcCtD
Nifedipine—Feeling abnormal—Capecitabine—colon cancer	0.000109	0.000856	CcSEcCtD
Nifedipine—Malaise—Methotrexate—colon cancer	0.000109	0.000854	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—colon cancer	0.000108	0.000851	CcSEcCtD
Nifedipine—Gastrointestinal pain—Capecitabine—colon cancer	0.000108	0.000849	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—colon cancer	0.000108	0.000848	CcSEcCtD
Nifedipine—Cough—Methotrexate—colon cancer	0.000105	0.000827	CcSEcCtD
Nifedipine—Urticaria—Capecitabine—colon cancer	0.000105	0.000825	CcSEcCtD
Nifedipine—Body temperature increased—Capecitabine—colon cancer	0.000104	0.000821	CcSEcCtD
Nifedipine—Abdominal pain—Capecitabine—colon cancer	0.000104	0.000821	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—colon cancer	0.000102	0.000807	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—colon cancer	0.000102	0.000807	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—colon cancer	0.000102	0.000807	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000102	0.000801	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—colon cancer	0.000101	0.000797	CcSEcCtD
Nifedipine—ABCB1—lymph node—colon cancer	0.000101	0.00189	CbGeAlD
Nifedipine—Confusional state—Methotrexate—colon cancer	9.91e-05	0.00078	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—colon cancer	9.82e-05	0.000773	CcSEcCtD
Nifedipine—Hypersensitivity—Capecitabine—colon cancer	9.72e-05	0.000765	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—colon cancer	9.63e-05	0.000758	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—colon cancer	9.62e-05	0.000757	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—colon cancer	9.54e-05	0.000751	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—colon cancer	9.5e-05	0.000747	CcSEcCtD
Nifedipine—Asthenia—Capecitabine—colon cancer	9.47e-05	0.000745	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—colon cancer	9.37e-05	0.000737	CcSEcCtD
Nifedipine—Pruritus—Capecitabine—colon cancer	9.34e-05	0.000735	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—colon cancer	9.18e-05	0.000722	CcSEcCtD
Nifedipine—Diarrhoea—Capecitabine—colon cancer	9.03e-05	0.000711	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—colon cancer	8.95e-05	0.000704	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—colon cancer	8.89e-05	0.000699	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—colon cancer	8.82e-05	0.000694	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—colon cancer	8.76e-05	0.000689	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—colon cancer	8.73e-05	0.000687	CcSEcCtD
Nifedipine—Dizziness—Capecitabine—colon cancer	8.73e-05	0.000687	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—colon cancer	8.65e-05	0.000681	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—colon cancer	8.54e-05	0.000672	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—colon cancer	8.48e-05	0.000668	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—colon cancer	8.47e-05	0.000667	CcSEcCtD
Nifedipine—Pain—Methotrexate—colon cancer	8.4e-05	0.000661	CcSEcCtD
Nifedipine—Vomiting—Capecitabine—colon cancer	8.39e-05	0.00066	CcSEcCtD
Nifedipine—Rash—Capecitabine—colon cancer	8.32e-05	0.000655	CcSEcCtD
Nifedipine—Dermatitis—Capecitabine—colon cancer	8.31e-05	0.000654	CcSEcCtD
Nifedipine—Headache—Capecitabine—colon cancer	8.27e-05	0.000651	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—colon cancer	8.1e-05	0.000637	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—colon cancer	8.03e-05	0.000632	CcSEcCtD
Nifedipine—Nausea—Capecitabine—colon cancer	7.84e-05	0.000617	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—colon cancer	7.8e-05	0.000614	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—colon cancer	7.77e-05	0.000611	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—colon cancer	7.77e-05	0.000611	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—colon cancer	7.24e-05	0.00057	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—colon cancer	7.05e-05	0.000555	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—colon cancer	6.95e-05	0.000547	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—colon cancer	6.72e-05	0.000529	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—colon cancer	6.5e-05	0.000511	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—colon cancer	6.25e-05	0.000492	CcSEcCtD
Nifedipine—Rash—Methotrexate—colon cancer	6.19e-05	0.000487	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—colon cancer	6.19e-05	0.000487	CcSEcCtD
Nifedipine—Headache—Methotrexate—colon cancer	6.15e-05	0.000484	CcSEcCtD
Nifedipine—Nausea—Methotrexate—colon cancer	5.84e-05	0.000459	CcSEcCtD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.58e-06	9.4e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PPARG—colon cancer	6.56e-06	9.37e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ABCB1—colon cancer	6.55e-06	9.36e-05	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—AKT1—colon cancer	6.52e-06	9.31e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ABCB1—colon cancer	6.5e-06	9.27e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—TYMS—colon cancer	6.44e-06	9.19e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PPARG—colon cancer	6.43e-06	9.17e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PPARG—colon cancer	6.41e-06	9.15e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PTGS2—colon cancer	6.4e-06	9.13e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PPARG—colon cancer	6.38e-06	9.11e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—TYMS—colon cancer	6.38e-06	9.11e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—PIK3CA—colon cancer	6.37e-06	9.1e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—PIK3CA—colon cancer	6.37e-06	9.1e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—HRAS—colon cancer	6.35e-06	9.06e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PIK3CA—colon cancer	6.28e-06	8.97e-05	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—AKT1—colon cancer	6.23e-06	8.89e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PPARG—colon cancer	6.18e-06	8.82e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PPARG—colon cancer	6.18e-06	8.82e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—HRAS—colon cancer	6.14e-06	8.77e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—HRAS—colon cancer	6.14e-06	8.77e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—HRAS—colon cancer	6.1e-06	8.7e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PPARG—colon cancer	6.06e-06	8.65e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.04e-06	8.62e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—FGFR3—colon cancer	6.02e-06	8.6e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—AKT1—colon cancer	6.02e-06	8.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—AKT1—colon cancer	6.02e-06	8.6e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTGS2—colon cancer	6e-06	8.56e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—HRAS—colon cancer	5.9e-06	8.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—HRAS—colon cancer	5.9e-06	8.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—FGFR3—colon cancer	5.83e-06	8.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—FGFR3—colon cancer	5.83e-06	8.32e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CTNNB1—colon cancer	5.81e-06	8.3e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—EP300—colon cancer	5.8e-06	8.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTGS2—colon cancer	5.8e-06	8.28e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTGS2—colon cancer	5.8e-06	8.28e-05	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—AKT1—colon cancer	5.73e-06	8.18e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CDKN1A—colon cancer	5.68e-06	8.11e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.67e-06	8.1e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CTNNB1—colon cancer	5.62e-06	8.03e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CTNNB1—colon cancer	5.62e-06	8.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—AKT1—colon cancer	5.61e-06	8e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PPARG—colon cancer	5.55e-06	7.93e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ABCB1—colon cancer	5.55e-06	7.93e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—APC—colon cancer	5.53e-06	7.9e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—NRAS—colon cancer	5.53e-06	7.9e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CDKN1A—colon cancer	5.49e-06	7.84e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CDKN1A—colon cancer	5.49e-06	7.84e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—TYMS—colon cancer	5.45e-06	7.78e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—AKT1—colon cancer	5.42e-06	7.74e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—AKT1—colon cancer	5.42e-06	7.74e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EP300—colon cancer	5.4e-06	7.71e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—AKT1—colon cancer	5.38e-06	7.68e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CTNNB1—colon cancer	5.37e-06	7.66e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—APC—colon cancer	5.35e-06	7.64e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—APC—colon cancer	5.35e-06	7.64e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—NRAS—colon cancer	5.35e-06	7.64e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—NRAS—colon cancer	5.35e-06	7.64e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—EP300—colon cancer	5.32e-06	7.59e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—SRC—colon cancer	5.25e-06	7.5e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CDKN1A—colon cancer	5.24e-06	7.48e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EP300—colon cancer	5.23e-06	7.46e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EP300—colon cancer	5.23e-06	7.46e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—AKT1—colon cancer	5.21e-06	7.43e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—AKT1—colon cancer	5.21e-06	7.43e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—BRAF—colon cancer	5.2e-06	7.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CTNNB1—colon cancer	5.19e-06	7.41e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CTNNB1—colon cancer	5.19e-06	7.41e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—colon cancer	5.16e-06	7.37e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—AKT1—colon cancer	5.13e-06	7.33e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—SRC—colon cancer	5.08e-06	7.25e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—SRC—colon cancer	5.08e-06	7.25e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CDKN1A—colon cancer	5.07e-06	7.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CDKN1A—colon cancer	5.07e-06	7.24e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—colon cancer	5.05e-06	7.22e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—NRAS—colon cancer	5.05e-06	7.21e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—colon cancer	5.04e-06	7.2e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—EGFR—colon cancer	5.04e-06	7.19e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—BRAF—colon cancer	5.03e-06	7.18e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—BRAF—colon cancer	5.03e-06	7.18e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—colon cancer	5.02e-06	7.17e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—EP300—colon cancer	4.99e-06	7.12e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.91e-06	7.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NRAS—colon cancer	4.89e-06	6.98e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NRAS—colon cancer	4.89e-06	6.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—EGFR—colon cancer	4.88e-06	6.96e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—EGFR—colon cancer	4.88e-06	6.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—colon cancer	4.86e-06	6.94e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—colon cancer	4.86e-06	6.94e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—SRC—colon cancer	4.85e-06	6.92e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARG—colon cancer	4.84e-06	6.91e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—EP300—colon cancer	4.83e-06	6.89e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—EP300—colon cancer	4.83e-06	6.89e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—colon cancer	4.77e-06	6.8e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—colon cancer	4.76e-06	6.8e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—SRC—colon cancer	4.69e-06	6.7e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—SRC—colon cancer	4.69e-06	6.7e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—NRAS—colon cancer	4.67e-06	6.66e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—colon cancer	4.61e-06	6.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—colon cancer	4.61e-06	6.57e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—colon cancer	4.6e-06	6.57e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARG—colon cancer	4.56e-06	6.51e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARG—colon cancer	4.52e-06	6.45e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—NRAS—colon cancer	4.51e-06	6.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—NRAS—colon cancer	4.51e-06	6.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—colon cancer	4.45e-06	6.36e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—colon cancer	4.45e-06	6.36e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—colon cancer	4.37e-06	6.24e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—colon cancer	4.37e-06	6.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—colon cancer	4.35e-06	6.21e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—colon cancer	4.35e-06	6.2e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFB1—colon cancer	4.34e-06	6.19e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—colon cancer	4.29e-06	6.13e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—EP300—colon cancer	4.29e-06	6.13e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ABCB1—colon cancer	4.29e-06	6.12e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—colon cancer	4.25e-06	6.07e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—colon cancer	4.23e-06	6.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—colon cancer	4.23e-06	6.04e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—TYMS—colon cancer	4.21e-06	6.01e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—colon cancer	4.21e-06	6.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—colon cancer	4.21e-06	6.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—colon cancer	4.2e-06	6e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—colon cancer	4.2e-06	6e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—EP300—colon cancer	4.2e-06	6e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.2e-06	5.99e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—EP300—colon cancer	4.2e-06	5.99e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFB1—colon cancer	4.19e-06	5.99e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFB1—colon cancer	4.19e-06	5.99e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—EP300—colon cancer	4.18e-06	5.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—colon cancer	4.11e-06	5.87e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—colon cancer	4.11e-06	5.87e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—colon cancer	4.05e-06	5.78e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—EP300—colon cancer	4.04e-06	5.77e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—EP300—colon cancer	4.04e-06	5.77e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—colon cancer	4.02e-06	5.73e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—colon cancer	4e-06	5.7e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—EP300—colon cancer	3.96e-06	5.66e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—colon cancer	3.94e-06	5.62e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—colon cancer	3.91e-06	5.59e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—colon cancer	3.91e-06	5.59e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—colon cancer	3.9e-06	5.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—colon cancer	3.89e-06	5.55e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—colon cancer	3.89e-06	5.55e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—colon cancer	3.87e-06	5.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—colon cancer	3.87e-06	5.52e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARG—colon cancer	3.86e-06	5.51e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—colon cancer	3.81e-06	5.43e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—colon cancer	3.79e-06	5.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—colon cancer	3.77e-06	5.38e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—colon cancer	3.77e-06	5.38e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CTNNB1—colon cancer	3.76e-06	5.36e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—colon cancer	3.7e-06	5.28e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—colon cancer	3.69e-06	5.27e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1A—colon cancer	3.67e-06	5.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—colon cancer	3.67e-06	5.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—colon cancer	3.67e-06	5.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CTNNB1—colon cancer	3.64e-06	5.19e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CTNNB1—colon cancer	3.64e-06	5.19e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—EP300—colon cancer	3.63e-06	5.19e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—colon cancer	3.59e-06	5.12e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—colon cancer	3.58e-06	5.11e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—colon cancer	3.58e-06	5.11e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—colon cancer	3.57e-06	5.1e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—colon cancer	3.57e-06	5.1e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—colon cancer	3.57e-06	5.1e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—colon cancer	3.56e-06	5.08e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1A—colon cancer	3.55e-06	5.07e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1A—colon cancer	3.55e-06	5.07e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—colon cancer	3.51e-06	5.01e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EP300—colon cancer	3.49e-06	4.99e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—colon cancer	3.46e-06	4.93e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—colon cancer	3.46e-06	4.93e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—colon cancer	3.41e-06	4.87e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SRC—colon cancer	3.4e-06	4.85e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EP300—colon cancer	3.38e-06	4.82e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EP300—colon cancer	3.38e-06	4.82e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—colon cancer	3.31e-06	4.72e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—colon cancer	3.3e-06	4.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—colon cancer	3.3e-06	4.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SRC—colon cancer	3.29e-06	4.69e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SRC—colon cancer	3.29e-06	4.69e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NRAS—colon cancer	3.27e-06	4.66e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—colon cancer	3.26e-06	4.66e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—colon cancer	3.21e-06	4.59e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—colon cancer	3.2e-06	4.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—colon cancer	3.2e-06	4.57e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—colon cancer	3.18e-06	4.53e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—EP300—colon cancer	3.17e-06	4.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NRAS—colon cancer	3.16e-06	4.51e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NRAS—colon cancer	3.16e-06	4.51e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—colon cancer	3.16e-06	4.51e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—colon cancer	3.16e-06	4.51e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—colon cancer	3.11e-06	4.44e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—colon cancer	3.1e-06	4.43e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—colon cancer	3.09e-06	4.41e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—colon cancer	3.04e-06	4.34e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—colon cancer	3.04e-06	4.34e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFB1—colon cancer	3.04e-06	4.33e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—colon cancer	3.01e-06	4.3e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—colon cancer	2.99e-06	4.27e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—colon cancer	2.99e-06	4.27e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—EP300—colon cancer	2.98e-06	4.26e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARG—colon cancer	2.98e-06	4.26e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—colon cancer	2.98e-06	4.25e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—EP300—colon cancer	2.96e-06	4.22e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—colon cancer	2.94e-06	4.2e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—colon cancer	2.94e-06	4.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFB1—colon cancer	2.94e-06	4.19e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFB1—colon cancer	2.94e-06	4.19e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—colon cancer	2.93e-06	4.19e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—colon cancer	2.92e-06	4.16e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—colon cancer	2.92e-06	4.16e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—colon cancer	2.88e-06	4.11e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—colon cancer	2.88e-06	4.11e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—colon cancer	2.81e-06	4.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—colon cancer	2.72e-06	3.88e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—colon cancer	2.72e-06	3.88e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—colon cancer	2.69e-06	3.84e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—colon cancer	2.59e-06	3.7e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—colon cancer	2.58e-06	3.69e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—colon cancer	2.54e-06	3.63e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—colon cancer	2.54e-06	3.62e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—EP300—colon cancer	2.53e-06	3.61e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—colon cancer	2.52e-06	3.6e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—colon cancer	2.5e-06	3.57e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—colon cancer	2.5e-06	3.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—colon cancer	2.5e-06	3.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—colon cancer	2.44e-06	3.49e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—colon cancer	2.44e-06	3.49e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—colon cancer	2.42e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—colon cancer	2.42e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—colon cancer	2.4e-06	3.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—colon cancer	2.39e-06	3.41e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—colon cancer	2.35e-06	3.35e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—colon cancer	2.34e-06	3.34e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—colon cancer	2.31e-06	3.3e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—colon cancer	2.31e-06	3.3e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—colon cancer	2.21e-06	3.15e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—colon cancer	2.2e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—colon cancer	2.19e-06	3.12e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—colon cancer	2.11e-06	3.01e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—colon cancer	2.04e-06	2.91e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—colon cancer	2.04e-06	2.91e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—EP300—colon cancer	1.95e-06	2.78e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—colon cancer	1.91e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—colon cancer	1.87e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—colon cancer	1.8e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—colon cancer	1.79e-06	2.55e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—colon cancer	1.53e-06	2.18e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—colon cancer	1.44e-06	2.06e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—colon cancer	1.18e-06	1.68e-05	CbGpPWpGaD
